LoginRegister
    USIBC urges govt to ease regulatory curbs on APIs, medical devicesUSIBC urges govt to ease regulatory curbs on APIs, medical devices
    Novartis CEO says Malaria drug is biggest hope against coronavirus - SonntagsZeitungNovartis CEO says Malaria drug is biggest hope against coronavirus - SonntagsZeitung
    Sun Pharma: USFDA classifies Halol facility as Official Action IndicatedSun Pharma: USFDA classifies Halol facility as Official Action Indicated
    Mylan, Lupin Announce Positive CHMP Opinion for NepextoMylan, Lupin Announce Positive CHMP Opinion for Nepexto
    NPPA directs 3 pharma cos to maintain stock of atleast 2.2 crore tablets of FDC Lopinavir and RitoavirNPPA directs 3 pharma cos to maintain stock of atleast 2.2 crore tablets of FDC Lopinavir and...
    Novartis, Life sciences companies commit to fight against COVID-19 pandemic alongside Bill & Melinda Gates FoundationNovartis, Life sciences companies commit to fight against COVID-19 pandemic alongside Bill & Melinda...
    Roche Venclexta/Venclyxto combination shows promising results in phase III VIALE-A study in Leukemia patientsRoche Venclexta/Venclyxto combination shows promising results in phase III VIALE-A study in Leukemia...
    USFDA approves Pfizer supplemental New Drug Application for EUCRISA (crisaborole) ointment for children with eczemaUSFDA approves Pfizer supplemental New Drug Application for EUCRISA (crisaborole) ointment for...
    Mylan, Pfizer Upjohn merger gets delayed in light on coronavirusMylan, Pfizer Upjohn merger gets delayed in light on coronavirus
    Philips to ramp up production of ventilators in coronavirus fightPhilips to ramp up production of ventilators in coronavirus fight
    Prophylaxis effect of hydroxychloroquine in COVID-19: Rising Pharmaceuticals, Laurus Labs collaborate to support University of Minnesota researchProphylaxis effect of hydroxychloroquine in COVID-19: Rising Pharmaceuticals, Laurus Labs...
    With USFDA nod Abbott set to launch its point of care 5 mins coronavirus test-ID NOW COVID-19With USFDA nod Abbott set to launch its point of care 5 mins coronavirus test-ID NOW COVID-19
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    sidekick